Skip to main content
SpringerLink
Log in

Costs of inadequate allergy care in EU: GA2LEN review

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Global Allergy and Asthma European Network

  2. total costs to health services and society, including direct costs, indirect costs, intangible costs and opportunity costs

  3. assuming 20% prevalence of allergic diseases and 10% impairment due to undertreatment

  4. assuming 35% prevalence of allergic diseases and 20% impairment due to undertreatment

Reference

  • Zuberbier T, et al. Economic Burden of Inadequate Management of Allergic Diseases in the European Union: a GA(2)LEN Review. Allergy : 26 Jun 2014. Available from: URL: http://doi.org/10.1111/all.12470

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of inadequate allergy care in EU: GA2LEN review. PharmacoEcon Outcomes News 708, 5 (2014). https://doi.org/10.1007/s40274-014-1420-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1420-z

Search

Navigation